Clinical correlation between 99mTc-TRODAT-1 SPECT and parkinsonism
Objective: Correlate the clinical parkinsonism and TRODAT. Background: 99mTc-TRODAT-1 SPECT is well documented method for dopamine transporter survey. Clinical use was usually for Parkinsonism in…91 years old woman with Sjogren’s syndrome and Parkinsonism
Objective: To introduce a very old woman case of Sjögren´s syndrome (SS) and Parkinsonism as well as to review previously reported cases. Background: Movement disorders…Quantitative assessment of the hand motor symptoms in Parkinson’s disease based on a custom wearable device: A Proof-of-Principle Study
Objective: The objective of this study was to evaluate the feasibility of a wrist-worn wearable device to assist with the quantitative assessment of hand motor…Single limb stance test performance – Difference between tremor dominant and akinetic rigid dominant parkinson’s disease – A pilot study
Objective: The objective of the study is to compare single-limb stance test performance between tremor dominant (TD) and akinetic rigid dominant (ARD) Parkinson's disease patients.…Basal Ganglionic Lesions in Egyptian Children: Radiological Findings in Correlation with Etiology and Clinical Manifestations
Objective: to determine the etiology of basal ganglionic disorders in a sample of Egyptian children. Background: In childhood, the metabolic activity of the basal ganglia…Recruitment of Minority populations with Parkinson’s disease at an Urban Hospital
Objective: To evaluate diagnostic disparities in Parkinson’s disease (PD) through recruitment of underrepresented minorities into a PD screening study. Background: African-Americans are less likely than…Do motor symptoms influence on malnutrition in Parkinson`s disease patients?
Objective: The aim of this study was to determine the prevalence of malnutrition and to analyze influence of age, sex, disease duration and motor symptoms…The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.
Objective: To present highlights from the Patient-Focused Drug Development (PFDD) meetings held at FDA for Parkinson’s disease (PD) and Huntington’s disease (HD) to raise awareness…Increased and symmetric expression of rigidity in early Parkinson’s disease with abnormal REM sleep without atonia
Objective: The purpose of this study was to compare the level and bilateral expression of upper arm rigidity between people with early stage Parkinson’s disease…Assessing Parkinson’s disease motor symptoms using supervised learning algorithms
Objective: Implantable brain stimulators are now an established method of treating Parkinson’s Disease (PD). Determination of optimal neural stimulation parameters is complex and clinically demanding. The goal of…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- Next Page »